Siren, L.L.C. Revolution Medicines, Inc. Transaction History
Siren, L.L.C.
- $1.76 Trillion
- Q1 2025
A detailed history of Siren, L.L.C. transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Siren, L.L.C. holds 563,755 shares of RVMD stock, worth $22.9 Million. This represents 1.13% of its overall portfolio holdings.
Number of Shares
563,755
Previous 571,548
1.36%
Holding current value
$22.9 Million
Previous $25 Billion
20.26%
% of portfolio
1.13%
Previous 1.1%
Shares
3 transactions
Others Institutions Holding RVMD
# of Institutions
303Shares Held
189MCall Options Held
186KPut Options Held
672K-
Vanguard Group Inc Valley Forge, PA16.6MShares$674 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA13.5MShares$549 Million2.75% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$544 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA11.8MShares$478 Million0.08% of portfolio
-
Janus Henderson Group PLC London, X010.2MShares$414 Million0.21% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $3.56B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...